miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) for Neuropathy: Mitochondrial Repair Evidence

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Quantified confidence (this ledger): 0.37 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

SS-31 (Elamipretide) — Peptide Evidence Score (source s1)

Mechanism summary from evidence framework page.

Evidence type: Published research.

Elamipretide Topical Ophthalmic Solution for the Treatment of Subjects with Leber Hereditary Optic Neuropathy: A Randomized Trial (source s2)

Phase II human trial details for LHON.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice (source s3)

Mouse study abstract detailing mitochondrial and behavioral outcomes.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

What people say on Reddit

My Experience Treating my ME/CFS with mitochondrial peptide SS-31 — Reddit, r/cfs (source s4)

User anecdote on sensory recovery.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain 2cd73f80fe45 · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
Phase II randomized trial of topical elamipretide in 12 LHON patients assessed safety and visual outcomes over 52 weeks.
sources: s2
human
No large human trials exist for common peripheral neuropathies such as diabetic neuropathy.
preclinical
In LPS mouse model, SS-31 reversed hippocampal mitochondrial dysfunction, lowered ROS and inflammation, preserved synapses, and improved memory tests.
sources: s3
mechanisticlow confidence
SS-31 binds cardiolipin to stabilize inner mitochondrial membrane and reduce ROS.
sources: s1
anecdotallow confidence
Reddit users with CFS/long COVID report subjective energy, cognitive, and one case of sensory nerve improvement after SS-31.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:51
SS-31 (Elamipretide) for Neuropathy: Mitochondrial Repair Evidence · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Neuropathy
Slug: ss-31-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"d
it output
{
  "slug": "ss-31-neuropathy",
  "title": "SS-31 (Elamipretide) for Neuropathy: Mitochondrial Repair Evidence",
  "body": "## What's breaking down\n\nNeuropathy often stems from mitochondrial dysfunction inside neurons. Damaged mitochondria leak reactive oxygen species, impair ATP production, and trigger cell death or poor signaling along nerves. This creates a repair deficit where breakdown outruns regeneration. Oxidative stress and inflammation compound the issue in many cases, whether from metabolic stress, injury, or genetic mitochondrial defects. The result is persistent nerve signaling problems rather than simple symptom masking.\n\n## Why SS-31 (Elamipretide) might help you\n\nIf mitochondrial cardiolipin instability sits at the root of your nerve energy failure, SS-31 (Elamipretide) is discussed because it binds cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, supports electron transport chain efficiency, and lowers excess ROS production. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain. The logic chain runs: mitochondrial stabilization → better ATP output in neurons → reduced oxidative damage → support for nerve maintenance pathways.\n\n## How these fit together\n\nSingle-compound focus. SS-31 (Elamipretide) maps directly to the mitoc
177ad9f90adffa76
Machine verification: /api/articles/ss-31-neuropathy/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Phase II randomized trial of topical elamipretide in 12 LHON patients assessed safety and visual outcomes over 52 weeks."?
ask ss-31-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No large human trials exist for common peripheral neuropathies such as diabetic neuropathy."?
ask ss-31-neuropathy claim c5 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In LPS mouse model, SS-31 reversed hippocampal mitochondrial dysfunction, lowered ROS and inflammation, preserved synapses, and improved mem…"?
ask ss-31-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "SS-31 binds cardiolipin to stabilize inner mitochondrial membrane and reduce ROS."?
ask ss-31-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users with CFS/long COVID report subjective energy, cognitive, and one case of sensory nerve improvement after SS-31."?
ask ss-31-neuropathy claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on sensory recovery."
ask ss-31-neuropathy source s4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for Neuropathy: Mitochondrial Repair Evidence — and what would you need me to tell you first?
ask ss-31-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for Neuropathy: Mitochondrial Repair Evidence (studies vs anecdotes)?
ask ss-31-neuropathy good bad experiences · paste includes §SELF
ss-31-neuropathy · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 38560 tokens · $0 · 2 models
chain head 6c346e5bea7e9486
write grok/grok-4.3 · 2026-06-29 23:51 · 38560 tok · 343e1b875b0d
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · 6c346e5bea7e
verify chain →
Live ledger · 17 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:42
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:27
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:27
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 15:48
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 14:37
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 09:21
view full ledger & cards →
REST + ledger
read GET /api/articles/ss-31-neuropathy · GET /api/articles/ss-31-neuropathy?format=post (the editable body)
create/replace POST /api/articles/ss-31-neuropathy · PUT /api/articles/ss-31-neuropathy (replace, keeps revision) · PATCH /api/articles/ss-31-neuropathy (merge)
delete DELETE /api/articles/ss-31-neuropathy
writes need header x-terminal-key
LLM bundle GET /api/articles/ss-31-neuropathy/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim ss-31-neuropathy|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →